List of Par Pharmaceutical patents

Patents where

Current Assignee

Name

Par Pharmaceutical

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11779587 Vareniciline compound and process of manufacture thereof	Patent 11779587 was granted and assigned to Par Pharmaceutical on October, 2023 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	11779587	October 10, 2023
‌ US Patent 11602537 Varenicline compound and process of manufacture thereof	Patent 11602537 was granted and assigned to Par Pharmaceutical on March, 2023 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	11602537	March 14, 2023
‌ US Patent 11337938 Epinephrine formulations	Patent 11337938 was granted and assigned to Par Pharmaceutical on May, 2022 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	11337938	May 24, 2022
‌ US Patent 9375478 Vasopressin formulations for use in treatment of hypotension	Patent 9375478 was granted and assigned to Par Pharmaceutical on June, 2016 by the United States Patent and Trademark Office.		Par Pharmaceutical	United States Patent and Trademark Office	9375478	June 28, 2016
‌ US Patent 9937223 Vasopressin formulations for use in treatment of hypotension	Patent 9937223 was granted and assigned to Par Pharmaceutical on April, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9937223	April 10, 2018
‌ US Patent 9981006 Vasopressin formulations for use in treatment of hypotension	Patent 9981006 was granted and assigned to Par Pharmaceutical on May, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9981006	May 29, 2018
‌ US Patent 9750785 Vasopressin formulations for use in treatment of hypotension	Patent 9750785 was granted and assigned to Par Pharmaceutical on September, 2017 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9750785	September 5, 2017
‌ US Patent 9968649 Vasopressin formulations for use in treatment of hypotension	Patent 9968649 was granted and assigned to Par Pharmaceutical on May, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9968649	May 15, 2018
‌ US Patent 9919026 Vasopressin formulations for use in treatment of hypotension	Patent 9919026 was granted and assigned to Par Pharmaceutical on March, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9919026	March 20, 2018
‌ US Patent 10130592 Epinephrine formulations	Patent 10130592 was granted and assigned to Par Pharmaceutical on November, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	10130592	November 20, 2018
‌ US Patent 9993520 Vasopressin formulations for use in treatment of hypotension	Patent 9993520 was granted and assigned to Par Pharmaceutical on June, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9993520	June 12, 2018
‌ US Patent 11097023 Pre-filled syringe containing sugammadex	Patent 11097023 was granted and assigned to Par Pharmaceutical on August, 2021 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	11097023	August 24, 2021
‌ US Patent 9744239 Vasopressin formulations for use in treatment of hypotension	Patent 9744239 was granted and assigned to Par Pharmaceutical on August, 2017 by the United States Patent and Trademark Office.		Par Pharmaceutical	United States Patent and Trademark Office	9744239	August 29, 2017
‌ US Patent 10920278 Method to treat hypotension using vasopressin in certain genotypes	Patent 10920278 was granted and assigned to Par Pharmaceutical on February, 2021 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	10920278	February 16, 2021
‌ US Patent 9925234 Vasopressin formulations for use in treatment of hypotension	Patent 9925234 was granted and assigned to Par Pharmaceutical on March, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9925234	March 27, 2018
‌ US Patent 9974827 Vasopressin formulations for use in treatment of hypotension	Patent 9974827 was granted and assigned to Par Pharmaceutical on May, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9974827	May 22, 2018
‌ US Patent 10844435 Method to treat hypotension using vasopressin in certain genotypes	Patent 10844435 was granted and assigned to Par Pharmaceutical on November, 2020 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	10844435	November 24, 2020
‌ US Patent 10624864 Epinephrine formulations	Patent 10624864 was granted and assigned to Par Pharmaceutical on April, 2020 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	10624864	April 21, 2020
‌ US Patent 9295657 Epinephrine formulations	Patent 9295657 was granted and assigned to Par Pharmaceutical on March, 2016 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9295657	March 29, 2016
‌ US Patent 9687526 Vasopressin formulations for use in treatment of hypotension	Patent 9687526 was granted and assigned to Par Pharmaceutical on June, 2017 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9687526	June 27, 2017
‌ US Patent 9962422 Vasopressin formulations for use in treatment of hypotension	Patent 9962422 was granted and assigned to Par Pharmaceutical on May, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9962422	May 8, 2018
‌ US Patent 9925233 Vasopressin formulations for use in treatment of hypotension	Patent 9925233 was granted and assigned to Par Pharmaceutical on March, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9925233	March 27, 2018
‌ US Patent 9744209 Vasopressin formulations for use in treatment of hypotension	Patent 9744209 was granted and assigned to Par Pharmaceutical on August, 2017 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	9744209	August 29, 2017
‌ US Patent 11207372 Vasopressin formulations for use in treatment of hypotension	Patent 11207372 was granted and assigned to Par Pharmaceutical on December, 2021 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	11207372	December 28, 2021
‌ US Patent 10010575 Vasopressin formulations for use in treatment of hypotension	Patent 10010575 was granted and assigned to Par Pharmaceutical on July, 2018 by the United States Patent and Trademark Office.	Par Pharmaceutical	Par Pharmaceutical	United States Patent and Trademark Office	10010575	July 3, 2018

Results per page:

28 results

0 selected

28 results

0 selected